Dr. Larry Hirsch, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.

Home / Dr. Larry Hirsch

Dr. Larry Hirsch

Dr. Larry Hirsch is the Vice President of Global Medical Affairs, Diabetes Care Business at Becton Dickinson. He is a graduate of the University of Rochester and Harvard Medical School, and board-certified in Internal Medicine and Endocrinology Metabolism. Before joining BD, he was the Assistant Professor of Medicine at Northwestern University and spent over 17 years at Merck in various roles in clinical drug development.

Dr. Larry Hirsch, Part 4: Infusion Set Comparison

Nov 23, 2015 Blood Glucose Control, Devices, Exclusive Interviews

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. In this final installment, Dr. Hirsch summarizes his ADA 2015 presentation, including a comparison of the BD infusion set to the current popular model, and images showing the fluid within infusion sets as captured by MRI and ultrasound.

Dr. Larry Hirsch, Part 2: BD Investigation Into Infusion Sets

Nov 9, 2015 Exclusive Interviews

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice PresidLarry Hirschent of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. This week, Dr. Hirsch shares the results of his investigation into infusion sets, the "achilles heel of pumps," which have rarely been the focus of past research. BD is working toward an innovative change to this common technology.

Dr. Larry Hirsch, Part 1: Efficacy of the Nano Needle in Obese Patients

Oct 26, 2015 Exclusive Interviews, Insulin Therapy Center, Obesity

Diabetes in Control publisher Steve Freed meets with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. Dr. Hirsch talks about the work toward improving patient experience when taking injections and the results of a study on the nano needle use in obese patients.